Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Fidaxomycin is an oral antibiotic primarily used to treat diarrhea and colitis caused by Clostridium difficile infection (CDI). It exerts its antibacterial effect by inhibiting bac···【more】
Article source：Captain MedicineRelease date：2026-02-28Recommended：141
Fidaxomycin (Fidaxomicin) prices vary depending on specifications, purchasing channels, and regional differences. The reference price is subject to the actual purchase channel. Thi···【more】
Article source：Captain MedicineRelease date：2026-02-28Recommended：128
The price of Fidaxomicin varies due to factors such as specification, region, and sales channel. The specific cost should be based on the actual selling price at local hospitals or···【more】
Article source：Captain MedicineRelease date：2026-02-28Recommended：124
Sotorasib is a targeted therapy drug directed against the KRAS G12C mutation, primarily used for the treatment of malignant tumors such as non-small cell lung cancer. Common side e···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：130
During treatment with sotorasib, consuming large amounts of greasy food is generally not recommended. However, small or occasional intake is usually acceptable, depending on indivi···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：234
Selpercatinib is a targeted therapy for specific gene mutations (such as RET fusion-positive), primarily used to treat malignant tumors such as thyroid cancer and non-small cell lu···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：129
Selpercatinib is a targeted therapy designed for specific gene mutations (such as RET fusions or mutations), primarily used to treat malignancies like non-small cell lung cancer an···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：111
The price of stiripentol is influenced by factors such as specification, dosage, and purchasing channel, typically ranging from hundreds to thousands of yuan. The exact cost should···【more】
Article source：Captain MedicineRelease date：2026-02-27Recommended：169
Mobocertinib is an oral targeted therapy primarily used for the treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) with specific genetic mutations. Its ···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：101
Mobocertinib is a targeted therapy drug for non-small cell lung cancer (NSCLC) with EGFR exon 20 insertion mutations. Its common side effects include diarrhea, rash, stomatitis, na···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：128
The current price of Mobocertinib after medical insurance reimbursement in China is influenced by specific circumstances. If you choose the generic version produced in India, the p···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：113
The current price of Mobocertinib is influenced by purchasing channels, regional policies, and medical insurance coverage. This medication must be used strictly under the guidance ···【more】
Article source：Captain MedicineRelease date：2026-02-26Recommended：136
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：4622025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：6432024-09-07
On May 28, 2026, AstraZeneca announced that its immunotherapy drug Imfinzi (durvalumab) in combinati···【more】
Recommended：1042026-01-06
On December 12, 2025, the U.S. Food and Drug Administration (FDA) approved niraparib in combination ···【more】
Recommended：4222025-15-12
The U.S. Food and Drug Administration (FDA) announced today that it has approved Omisirge (omidubice···【more】
Recommended：4472025-10-12
On December 4, 2025, the U.S. Food and Drug Administration (FDA) approved lisocabtagene maraleucel (···【more】
Recommended：4312025-08-12
On December 3, 2025, the U.S. Food and Drug Administration (FDA) granted full approval to pirtobruti···【more】
Recommended：4862025-04-12
Primary analysis data from the randomized, double-blind, placebo-controlled phase III HER2CLIMB-02 s···【more】
Recommended：3972025-01-12
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
